…Kearon et al ). Epidemiology of pulmonary embolism Venous thromboembolism (VTE) is the third leading cardiovascular cause of death worldwide. Only stroke and acute myocardial infarction…

…thromboembolism when a DOAC cannot be used (interactions, cost, adherence, pregnancy after the first trimester under specialist care). Rheumatic mitral stenosis with atrial fibrillation. In…

…least 3 months. Extended treatment in unprovoked pulmonary embolism, a persisting risk factor, or recurrence. Special situations Situation Comment : : Pregnancy Leg ultrasound first. CT pulmonary…

…has been the foundational tool for assessing thromboembolic risk. However, recent epidemiological data have prompted a divergence in international guidelines regarding the role of biological…

Echocardiography Cardiac thromboembolism Thromboembolism is a leading cause of death worldwide (1). Emboli originating in the atria, left atrial appendage (LAA), ventricles, valves, and proximal…

…Consequently, the absence of AF during intermittent monitoring is not sufficient evidence that thromboembolic risk is low. In the setting of acute coronary syndrome, AF…

…pulmonary congestion Reduced exercise capacity Symptoms or signs of heart failure Haemodynamic instability Myocardial ischaemic symptoms or electrocardiographic changes Thromboembolic complications, particularly stroke In ACS…

…multiple villi . These myxomas are more likely to embolize (Cardiac Thromboembolism). There are genetic syndromes that result in the emergence of multiple myxomas. Papillary fibroelastoma…

…Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart Survey on Atrial…

…and calcific aortic valve stenosis. Lp(a) is not associated with venous thromboembolism in prospective epidemiological studies. Its biological effects appear to differ from those…